Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    0.00 (0.00%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Result of AGM

29 Apr 2026 15:47

RNS Number : 4524C
Elementis PLC
29 April 2026
 

Elementis plc

Result of 2026 AGM & Board Changes

 

The Company's AGM was held today (29 April 2026) at the offices of A&O Shearman Sterling LLP, One Bishops Square, London, E1 6AD and all resolutions proposed were passed on a poll.

 

For information, the following table shows the poll results for the Meeting. The total number of shares in issue (ISC) as at 10.00am on 27 April 2026 was 572,658,928. (Total voting rights: 572,611,396). The percentage figure shown in each column is the percentage of the total number of votes validly cast (under law) for each resolution (i.e. excludes votes withheld).

 

 

Resolution

Votes

For

%

Votes Against

%

Votes

Total

% of ISC voted

Votes Withheld

1.

To receive the annual report and accounts 2025

438,411,997

100.00

16,352

0.00

438,428,349

76.57%

204,281

2.

To declare a final dividend

438,622,106

100.00

439

0.00

438,622,545

76.60%

10,085

3.

To approve the Directors' remuneration report 2025

432,141,644

98.52

6,479,779

1.48

438,621,423

76.60%

11,207

4.

To elect Mike Humphrey

438,120,170

99.89

498,054

0.11

438,618,224

76.60%

14,406

5.

To elect Kath Kearney-Croft

435,817,500

99.36

2,800,724

0.64

438,618,224

76.60%

14,406

6.

To re-elect Maria Ciliberti

434,291,486

99.06

4,134,678

0.94

438,426,164

76.57%

206,466

7.

To re-elect Christopher Mills

277,790,064

63.33

160,829,264

36.67

438,619,328

76.60%

13,302

8.

To re-elect Luc van Ravenstein

437,522,604

99.75

1,096,724

0.25

438,619,328

76.60%

13,302

9.

To re-elect Trudy Schoolenberg

428,257,047

97.64

10,362,281

2.36

438,619,328

76.60%

13,302

10.

To re-elect Christine Soden

345,469,150

78.80

92,957,014

21.20

438,426,164

76.57%

206,466

11.

To re-elect Clement Woon

354,976,727

80.93

83,642,601

19.07

438,619,328

76.60%

13,302

12.

To appoint Ernst & Young LLP as Auditors

438,217,832

99.95

209,128

0.05

438,426,960

76.57%

205,670

13.

To authorise the Audit Committee to determine the Auditors' remuneration

438,215,445

99.95

206,923

0.05

438,422,368

76.57%

210,262

14.

To grant authority to the directors to allot shares

403,353,647

91.96

35,275,898

8.04

438,629,545

76.60%

3,085

15.

To authorise political donations

400,549,933

91.36

37,880,841

8.64

438,430,774

76.57%

201,856

16.

To approve the holding of general meetings at 14 clear days' notice*

419,345,492

95.60

19,287,121

4.40

438,632,613

76.60%

17

17.

To disapply pre-emption rights*

438,565,643

99.99

47,555

0.01

438,613,198

76.60%

19,432

18.

To disapply pre-emption rights for an acquisition or capital investment*

438,572,157

99.99

47,391

0.01

438,619,548

76.60%

13,082

19.

To renew the Company's authority to purchase own shares*

438,548,308

100.00

20,527

0.00

438,568,835

76.59%

63,795

20.

To approve the appropriation of distributable reserves, entry into buyback deed and entry into deeds of release*

436,645,148

99.99

24,275

0.01

436,669,423

76.26%

1,963,207

* Resolutions 16 to 20 were passed as special resolutions.

 

The Board notes that all resolutions were passed at today's AGM and thanks shareholders for their engagement and support. 

 

The Board notes that 36.67% of the votes cast in relation to Resolution 7 and 21.20% in relation to Resolution 10 were against the respective resolution. The views of shareholders are important to the Board, and the Chair will engage with the shareholders who voted against both these resolutions to consider any feedback received in relation to this result.

 

In accordance with Listing Rule 6.4.2R, copies of the resolutions, designated as being special business, passed at the AGM will be submitted to the National Storage Mechanism and will be available shortly for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

These voting results will also be available on the Company's website at https://www.elementis.com/investors/shareholder-information/annual-general-meeting/ later this afternoon.

 

Board and Committee Changes

 

The Board is pleased to confirm that Mike Humphrey has joined the Board.

 

Following the closure of the AGM held today, Trudy Schoolenberg has taken up her appointment as Chair of the Board, and Christine Soden as interim Senior Independent Director. John O'Higgins has stepped down from the Board. This follows the announcement made on 18 March.

 

The Board Committee membership is now as follows:

 

Audit Committee

Christine Soden (Committee Chair)

Maria Ciliberti

Mike Humphrey

Clement Woon

 

Nomination Committee

Trudy Schoolenberg (Committee Chair)

Maria Ciliberti

Mike Humphrey

Christopher Mills

Christine Soden

Clement Woon

 

Remuneration Committee

Clement Woon (Committee Chair)

Maria Ciliberti

Mike Humphrey

Trudy Schoolenberg

Christine Soden

 

 

 

 

 

 

 

 

 

Hannah Constantine

Group General Counsel & Company Secretary

020 8148 5966

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBSGDSLSDDGLC
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.